Business Context and Reporting Period
This Form 8-K Current Report was filed by Illumina, Inc. on June 18, 2004. The registrant is incorporated in Delaware and maintains its principal executive offices in San Diego, California. The report details a specific corporate transaction regarding the disposition of assets.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, or cash flow data for the reporting period. The only specific financial figures disclosed relate to a conditional asset sale:
- Asset Sale Price: $42 million for land and buildings in San Diego, California.
- Net Cash Proceeds: Approximately $16 million (estimated after repayment of an existing mortgage).
- Leaseback Term: Initial term of ten years.
Material Changes
On June 18, 2004, Illumina, Inc. entered into a conditional agreement to sell its San Diego property to Bernardo Property Advisors, Inc. and lease it back. This transaction represents a material change in the company's asset structure and potential liquidity position, contingent upon the successful closing of the initial public offering of Common Stock of BioMed Property Trust, Inc.
Outlook, Risks, and Contingencies
The transaction is subject to specific closing conditions, primarily the closing of the IPO for BioMed Property Trust, Inc. Management explicitly states that there can be no assurances that these conditions will be satisfied in a timely manner or at all. If the sale is not consummated, the anticipated cash inflow of $16 million will not be realized.
Investor Verification Checklist
- Verify the status of the BioMed Property Trust, Inc. IPO and whether closing conditions have been met.
- Confirm the exact amount of the existing mortgage to be repaid to validate the $16 million net cash estimate.
- Review the terms of the ten-year leaseback agreement for any financial covenants or rent obligations.
- Check for subsequent filings indicating if the transaction was completed, amended, or terminated.